LIFESCAPES raises $3.9M Series C for BMI-based stroke rehabilitation devices
Summary
LIFESCAPES, a Keio University-founded startup, has raised approximately $3.9 million (600 million yen) in a Series C round from investors including MSIVC2025V, Golden Asia Fund III, and SUMISEI-SBI. The Tokyo-based company develops brain-machine interface medical devices for severe hand paralysis rehabilitation after stroke, and will use the funding to expand into ASEAN markets starting with Malaysia.
Why it matters
LIFESCAPES' therapeutic BMI device received Japan's 'pioneering medical device' designation in December 2025, with clinical trials scheduled for summer 2026 aimed at securing public insurance coverage. The company's hand-type rehabilitation device has already been used in over 400 clinical cases in Japan, demonstrating strong early commercial demand for BCI-based neurorehabilitation.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items โ updated daily.
Start free trial